Breast cancer immunotherapy using scFv antibody-based approaches, a systematic review
- 29 August 2024
- journal article
- review article
- Published by Elsevier in Human Immunology
- Vol. 85 (5) , 111090
Abstract
No abstract availableKeywords
This publication has 136 references indexed in Scilit:
- Breast cancer brain metastasis: Current evidence and future directionsCancer Medicine, 2022
- Anti‐EGFR antibody‐drug conjugate for triple‐negative breast cancer therapyEngineering in Life Sciences, 2020
- Cancer stem cells: A review from origin to therapeutic implicationsJournal of Cellular Physiology, 2019
- Concise Reviews: Cancer Stem Cell Targeted Therapies: Toward Clinical SuccessStem Cells Translational Medicine, 2018
- A potent immunotoxin targeting fibroblast activation protein for treatment of breast cancer in miceInternational Journal of Cancer, 2015
- ScFv‐Decorated PEG‐PLA‐Based Nanoparticles for Enhanced siRNA Delivery to Her2+ Breast CancerAdvanced Healthcare Materials, 2014
- A novel single‐chain variable fragment antibody against FGF‐1 inhibits the growth of breast carcinoma cells by blocking the intracrine pathway of FGF‐1IUBMB Life, 2011
- Targeted photodynamic therapy with multiply‐loaded recombinant antibody fragmentsInternational Journal of Cancer, 2007
- Gene expression and function study of fusion immunotoxin anti-Her-2-scFv—SEC2 in Escherichia coliApplied Microbiology and Biotechnology, 2006
- Construction, expression, purification and functional analysis of recombinant 6C6 immunotoxin to human breast-tumor cellsScience China Life Sciences, 1999